Mirae Asset Global ETFs Holdings
DNTH icon

Mirae Asset Global ETFs Holdings’s Dianthus Therapeutics DNTH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
19,034
-13,005
-41% -$753K ﹤0.01% 1282
2025
Q4 		$1.32M Buy
32,039
+23,634
+281% +$916K ﹤0.01% 1367
2025
Q3 		$331K Sell
8,405
-3,686
-30% -$94.2K ﹤0.01% 2062
2025
Q2 		$224K Sell
12,091
-3,243
-21% -$60.8K ﹤0.01% 2220
2025
Q1 		$280K Buy
15,334
+618
+4% +$13.6K ﹤0.01% 2142
2024
Q4 		$320K Buy
14,716
+352
+2% +$9.05K ﹤0.01% 2136
2024
Q3 		$393K Buy
+14,364
New +$400K ﹤0.01% 2037

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DNTH Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Dianthus Therapeutics (DNTH) stake by 41% in Q1 2026, selling an estimated $753K and leaving 19,034 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Mirae Asset Global ETFs Holdings first reported a position in DNTH in Q3 2024 and has held it in 7 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 19,034 shares of Dianthus Therapeutics worth $1.59M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 13,005 Dianthus Therapeutics shares in Q1 2026, an estimated $753K.
  • Dianthus Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1282 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.